Submitted by Jennifer Campbell on
Advancing GI Patient Care will deliver focused, educational updates highlighting clinically relevant advances in the management of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders to approximately 200 GI Alliance healthcare providers. It will feature an interactive format to enhance the educational impact. Internationally renowned hepatologists and gastroenterologists will lead the development of educational content and will serve as program faculty. The faculty will review state-of-the art developments in gastrointestinal (GI) disorders and chronic liver disease (CLD), including, but not limited to, gastroparesis (GP), inflammatory bowel disease (IBD), irritable bowel syndrome (IBS), diet and GI cancer, C. difficile, hepatocellular carcinoma (HCC), hepatorenal syndrome (HRS), cirrhosis, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH).
The forum will deliver emerging science and incorporate expert opinions on best practices for the diagnosis and management of patients with CLD and GI disorders.